logo
Plus   Neg
Share
Email

Yum! Brands Q3 Profit Misses Estimates; Same-Store Sales Up 3%

Yum! Brands, Inc. (YUM) reported third-quarter earnings per share excluding special items of $0.80, a decrease of 23 percent from prior year. On average, 23 analysts polled by Thomson Reuters expected the company to report profit per share of $0.94, for the quarter. Analysts' estimates typically exclude special items. GAAP earnings per share was $0.81, a decline of 42 percent from prior year.

Third-quarter total revenues declined 4 percent to $1.34 billion. Analysts expected revenue of $1.34 billion, for the quarter. Worldwide system sales excluding foreign currency translation grew 8 percent, with KFC at 8 percent, Pizza Hut at 7 percent and Taco Bell at 7 percent. The company delivered same-store sale growth of 3 percent and net-new unit growth of 7 percent, led by continued strong performances at KFC International and Taco Bell.

For 2019, the company's 2019 adjusted EPS target is at least $3.75. Analysts expect the company to report profit per share of $3.86.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT